Breast Density In Women With Premature Ovarian Failure Or Postmenopausal Women Using Hormone Therapy: Analytical Cross-sectional Study [densidade Mamária Em Mulheres Com Falência Ovariana Prematura Ou Na Pós-menopausa E Em Uso De Terapia Hormonal: Estudo Transversal Analítico]

Context and objective: Studies on postmenopausal women have reported increased risk of breast cancer relating to the type and duration of hormone therapy (HT) used. Women with premature ovarian failure (POF) represent a challenge, since they require prolonged HT. Little is known about the impact of prolonged HT use on these women's breasts. This study aimed to evaluate the effects of one type of HT on the breast density of women with POF, compared with postmenopausal women. Design and setting: Cross-sectional study at the Department of Obstetrics and Gynecology, Universidade Estadual de Campinas (Unicamp). Methods: 31 women with POF and 31 postmenopausal women, all using HT consisting of conjugated equine estrogen combined with medroxyprogesterone acetate, and matched according to HT duration, were studied. Mammography was performed on all subjects and was analyzed by means of digitization or Wolfe's classification, stratified into two categories: Non-dense (N1 and P1 patterns) and dense (P2 and Dy). Results: No significant difference in breast density was found between the two groups through digitization or Wolfe's classification. From digitization, the mean breast density was 24.1% ± 14.6 and 18.1% ± 17.2 in the POF and postmenopausal groups, respectively (P = 0.15). Wolfe's classification identified dense breasts in 51.6% and 29.0%, respectively (P = 0.171). Conclusion: There was no difference in breast density between the women with POF and postmenopausal women, who had used HT for the same length of time. These results may help towards compliance with HT use among women with POF.1284211214Rossouw, J.E., Anderson, G.L., Prentice, R.L., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial (2002) JAMA, 288 (3), pp. 321-333Beral, V., Breast cancer and hormone-replacement therapy in the Million Women Study (2003) Lancet, 362 (9382), pp. 419-427. , Million Women Study CollaboratorsConner, P., Svane, G., Azavedo, E., Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy (2004) Fertil Steril, 81 (6), pp. 1617-1623Chen, F.P., Cheung, Y.C., Teng, L.F., Soong, Y.K., The relationship between mammographic density and duration of hormone therapy: Effects of estrogen and estrogen-progestin (2005) Hum Reprod, 20 (6), pp. 1741-1745Harvey, J., Scheurer, C., Kawakami, F.T., Hormone replacement therapy and breast density changes (2005) Climacteric, 8 (2), pp. 185-192Junkermann, H., von Holst, T., Lang, E., Rakov, V., Influence of different HRT regimens on mammographic density (2005) Maturitas, 50 (2), pp. 105-110Christodoulakos, G.E., Lambrinoudaki, I.V., Vourtsi, A.D., The effect of low dose hormone therapy on mammographic breast density (2006) Maturitas, 54 (1), pp. 78-85Kavanagh, A.M., Mitchell, H., Giles, G.G., Hormone replacement therapy and accuracy of mammographic screening (2000) Lancet, 355 (9200), pp. 270-274Banks, E., Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: A review (2001) J Med Screen, 8 (1), pp. 29-34Warren, R., Hormones and mammographic breast density (2004) Maturitas, 49 (1), pp. 67-78Armitage, M., Nooney, J., Evans, S., Recent concerns surrounding HRT (2003) Clin Endocrinol (Oxf), 59 (2), pp. 145-155Mann, R.D., Hormone replacement therapy and breast cancer risk: Studies of the last fifteen years (1992) Hormone replacement therapy and breast cancer risk, pp. 1-8. , In: Mann RD, editor, New Jersey: Parthenon Publishing GroupBoyd, N.F., Byng, J.W., Jong, R.A., Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study (1995) J Natl Cancer Inst, 87 (9), pp. 670-675Byrne, C., Schairer, C., Wolfe, J., Mammographic features and breast cancer risk: Effects with time, age, and menopause status (1995) J Natl Cancer Inst, 87 (21), pp. 1622-1629Maskarinec, G., Meng, L., A case-control study of mammographic densities in Hawaii (2000) Breast Cancer Res Treat, 63 (2), pp. 153-161Vachon, C.M., Kuni, C.C., Anderson, K., Anderson, V.E., Sellers, T.A., Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States) (2000) Cancer Causes Control, 11 (7), pp. 653-662Noh, J.J., Maskarinec, G., Pagano, I., Cheung, L.W., Stanczyk, F.Z., Mammographic densities and circulating hormones: A cross-sectional study in premenopausal women (2006) Breast, 15 (1), pp. 20-28Laya, M.B., Gallagher, J.C., Schreiman, J.S., Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern (1995) Radiology, 196 (2), pp. 433-437Collaborative Group on Hormonal Factors in Breast Cancer (1997) Lancet, 350 (9084), pp. 1047-1059. , Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancerMarugg, R.C., van der Mooren, M.J., Hendriks, J.H., Rolland, R., Ruijs, S.H., Mammographic changes in postmenopausal women on hormonal replacement therapy (1997) Eur Radiol, 7 (5), pp. 749-755Koukoulis, G.N., Hormone replacement therapy and breast cancer risk (2000) Ann N Y Acad Sci, 900, pp. 422-428Lundström, E., Wilczek, B., von Palffy, Z., Söderqvist, G., von Schoultz, B., Mammographic breast density during hormone replacement therapy: Effects of continuous combination, unopposed transdermal and low-potency estrogen regimens (2001) Climacteric, 4 (1), pp. 42-48Greendale, G.A., Palla, S.L., Ursin, G., The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: Results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study (2005) Am J Epidemiol, 162 (9), pp. 826-834de Moraes-Ruehsen, M., Jones, G.S., Premature ovarian failure (1967) Fertil Steril, 18 (4), pp. 440-461Cymberknoh, M., Mamografia digital (1994) Mastologia atual, pp. 75-78. , In: Dias EN, Caleffi M, Silva HMS, Figueira-Filho ASS, eds., Rio de Janeiro: RevinterWolfe, J.N., Breast patterns as an index of risk for developing breast cancer (1976) AJR Am J Roentgenol, 126 (6), pp. 1130-1137Snedecor, W.G., Cochram, W.G., The comparison of two samples (1989) Statistical methods, pp. 83-102. , In: Snedecor WG, Cochram WG, editors., 8thed Ames: Iowa State University PressPersson, I., Thurfjell, E., Holmberg, L., Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density (1997) J Clin Oncol, 15 (10), pp. 3201-3207Harvey, J.A., Bovbjerg, V.E., Quantitative assessment of mammographic breast density: Relationship with breast cancer risk (2004) Radiology, 230 (1), pp. 29-4